Sign up to save your podcasts
Or
Share Why Biopharma Investment Requires a Different Mindset
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Why Biopharma Investment Requires a Different Mindset
In the latest episode of Pathfinders, Noël Brown, Head of US Biotechnology Investment Banking at RBC Capital Markets, reveals why he’s feeling optimistic about M&A in biopharma and how leading in biotech investment and corporates needs visionary long-term thinking.
View all episodes
By RBC Capital Markets
5
1212 ratings
In the latest episode of Pathfinders, Noël Brown, Head of US Biotechnology Investment Banking at RBC Capital Markets, reveals why he’s feeling optimistic about M&A in biopharma and how leading in biotech investment and corporates needs visionary long-term thinking.
More shows like Pathfinders in Biopharma
View all
Motley Fool Money
3,228 Listeners
WSJ Your Money Briefing
1,713 Listeners
Exchanges
977 Listeners
Odd Lots
1,993 Listeners
WSJ Tech News Briefing
1,649 Listeners
The a16z Show
1,105 Listeners
The Long Run with Luke Timmerman
125 Listeners
The Readout Loud
337 Listeners
Wall Street Breakfast
1,044 Listeners
Thoughts on the Market
1,320 Listeners
The Journal.
6,097 Listeners
BioCentury This Week
34 Listeners
RBC's Markets in Motion
43 Listeners
Biotech Hangout
21 Listeners
Industries in Motion
10 Listeners
Powering Sustainable Ideas
0 Listeners
The Markets
80 Listeners
Strategic Alternatives
18 Listeners
The Top Line
17 Listeners
Macro Minutes
3 Listeners